Xia Tong, Xiang Ting, Xie Hailong
Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Institute of Cancer Research, School of Medicine, University of South China, Hengyang, Hunan 421001, P.R. China.
Oncol Lett. 2022 Mar;23(3):97. doi: 10.3892/ol.2022.13217. Epub 2022 Jan 27.
Cancer remains one of the most difficult diseases to treat. In the quest for early diagnoses to improve patient survival and prognosis, targeted therapies have become a hot research topic in recent years. Glycosylation is the most common posttranslational modification in mammalian cells. Core 1β1,3-galactosyltransferase (C1GALT1) is a key glycosyltransferase in the glycosylation process and is the key enzyme in the formation of the core 1 structure on which most complex and branched O-glycans are formed. A recent study reported that C1GALT1 was aberrantly expressed in tumors. In cancer cells, C1GALT1 is regulated by different factors. In the present review, the expression of C1GALT1 in different tumors and its possible molecular mechanisms of action are described and the role of C1GALT1 in cancer development is discussed.
癌症仍然是最难治疗的疾病之一。在寻求早期诊断以提高患者生存率和预后的过程中,靶向治疗近年来已成为一个热门研究课题。糖基化是哺乳动物细胞中最常见的翻译后修饰。核心1β1,3-半乳糖基转移酶(C1GALT1)是糖基化过程中的关键糖基转移酶,是核心1结构形成的关键酶,大多数复杂和分支的O-聚糖都在该结构上形成。最近的一项研究报告称,C1GALT1在肿瘤中异常表达。在癌细胞中,C1GALT1受不同因素调控。在本综述中,描述了C1GALT1在不同肿瘤中的表达及其可能的分子作用机制,并讨论了C1GALT1在癌症发展中的作用。